Following people with chronic inflammatory diseases in one hospital cohort
Follows adults with bowel, skin or joint inflammatory diseases over time at one hospital.
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Besancon
- Where
- Besançon, FranceSee the site
- Trial code
- Registry title
- Evolution and Treatments of Chronic Inflammatory Systemic Diseases
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 11 Dec 2019
- Expected to end
- Dec 2029
- Type of study
- Observational, 3 groups
- Record updated
- 27 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults treated at Besançon University Hospital for a long-term inflammatory bowel, joint or skin disease, to build a shared patient cohort.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Crohn's disease, ulcerative colitis or indeterminate colitis; rheumatoid arthritis, spondyloarthritis or psoriatic arthritis; psoriasis or Verneuil's disease. The diagnosis must meet the clinical, morphological and histological criteria (bowel) or the ACR 2010, modified New York, ASAS or CASPAR criteria (joints).
Main reasons for not taking part
- The patient opposes taking part
- Patients in an emergency situation
- Persons deprived of their liberty
- Protected minors or protected adults
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients treated for IBD (MC, UC or indeterminate colitis) in the gastroenterology department of Besançon University Hospital
- Subject meeting the clinical, morphological and histological diagnostic criteria for MC, UC or indeterminate colitis or
- Patients treated for chronic inflammatory rheumatism (RA, SpA, PsA) in the rheumatology department of the University Hospital of Besançon Subject meeting the ACR 2010 classification criteria of RA or modified New York criteria of Ankylosing spondylitis or ASAS criteria of axial or peripheral SpA or CASPAR criteria of PsA or
- Patients treated for chronic inflammatory skin disease (Psoriasis, Verneuil's disease) in the dermatology department of the University Hospital of Besançon
Who cannot take part
- Opposition of the patient
- Patients in emergency situation, persons deprived of their liberty, protected minors or adults
Where in France
- CHU BesançonBesançon, FranceContact: Charline Vauchy, PhDTaking people
About the trial
What the trial wants to find out
Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points. The pathologies concerned are inflammatory bowel diseases (IBD - Crohn's disease [MC] and ulcerative colitis [RCH]), chronic inflammatory skin diseases (psoriasis or Verneuil's disease) and chronic inflammatory rheumatic diseases (rheumatoid arthritis [RA] and spondyloarthritis [SpA] including psoriatic arthritis [PsA]). Presenting one of these diseases is associated with a higher risk of having a second inflammatory pathology, whether the latter is ophthalmological, dermatological, rheumatological or gastroenterological. An association of extra-articular manifestations is observed in 10 to 30% of patients with SpA, and an association of extra-intestinal manifestations is observed in approximately 30% of patients with IBD. No common database for chronic systemic inflammatory diseases currently exists in France.
The 3 groups in the trial
- Inflammatory bowel disease
- Chronic inflammatory rheumatic disease
- Chronic inflammatory skin diseases
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in the Gastroenterology, Dermatology and Rheumatology Departments of the University Hospital of Besançon
- Plain-language title
- Following people with chronic inflammatory diseases in one hospital cohortGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 27 November 2024